Literature DB >> 19894037

Inhibitors of TRP channels reveal stimulus-dependent differential activation of Ca2+ influx pathways in human neutrophil granulocytes.

Elena Pantaler1, Andreas Lückhoff.   

Abstract

A pharmacological characterization of Ca(2+) influx pathways in neutrophil granulocytes is problematic because of the lack of specific inhibitors. The activation of transient receptor potential cation channel, subfamily M, member 2 (TRPM2) channels by intracellular adenosine diphosphate ribose (ADPR), well characterized in neutrophils, is reportedly inhibited by 8-bromo-ADPR (8Br-ADPR). TRPM2 is blocked by N-(p-amylcinnamoyl)anthranilic acid (ACA) interfering with the pore, but ACA is as well effective on other transient receptor potential channels, especially transient receptor potential canonical (TRPC) channels. We wished to analyze whether ACA and 8Br-ADPR were suitable probes to demonstrate that different Ca(2+) entry pathways are activated in human neutrophil granulocytes by the receptor-dependent stimuli N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) and platelet-activating factor (PAF) and the receptor-independent thapsigargin. Ca(2+)-influx-related increases in [Ca(2+)](i) were calculated by comparing aliquots of fluo-3-loaded neutrophils in the presence and absence of extracellular Ca(2+). Moreover, Mn(2+) quenching was used in fura-2-loaded cells. We compared 8Br-ADPR with ACA. 8Br-ADPR was exclusively effective when Ca(2+) influx (or Mn(2+) quenching) was induced by fMLP; it did not affect influx when PAF or thapsigargin was the stimulus. ACA inhibited Ca(2+) influx significantly more strongly when this was induced by PAF than by fMLP. Moreover, it reduced thapsigargin-induced Ca(2+) influx. The contribution of TRPM2 to Ca(2+) influx in neutrophils strongly depends on the stimulus; it is sizeable in the case of fMLP and minimal in the case of PAF. PAF induces Ca(2+) entry pathways different from TRPM2; the inhibition by ACA suggests the contribution of channels of the TRPC family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894037     DOI: 10.1007/s00210-009-0464-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  55 in total

Review 1.  Neutrophil granules: a library of innate immunity proteins.

Authors:  Niels Borregaard; Ole E Sørensen; Kim Theilgaard-Mönch
Journal:  Trends Immunol       Date:  2007-07-12       Impact factor: 16.687

2.  Ca2+-induced exocytosis in individual human neutrophils: high- and low-affinity granule populations and submaximal responses.

Authors:  O Nüsse; L Serrander; D P Lew; K H Krause
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

3.  Two transduction sequences are necessary for neutrophil activation by receptor agonists.

Authors:  B Dewald; M Thelen; M Baggiolini
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

4.  Chemoattractant-induced respiratory burst: increases in cytosolic Ca2+ concentrations are essential and synergize with a kinetically distinct second signal.

Authors:  R Foyouzi-Youssefi; F Petersson; D P Lew; K H Krause; O Nüsse
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

5.  Cyclic ADP-ribose mediates formyl methionyl leucyl phenylalanine (fMLP)-induced intracellular Ca(2+) rise and migration of human neutrophils.

Authors:  Katsuya Morita; Minoru Saida; Norimitsu Morioka; Tomoya Kitayama; Yasumasa Akagawa; Toshihiro Dohi
Journal:  J Pharmacol Sci       Date:  2008-03-12       Impact factor: 3.337

6.  Store-operated Ca2+ channels formed by TRPC1, TRPC6 and Orai1 and non-store-operated channels formed by TRPC3 are involved in the regulation of NADPH oxidase in HL-60 granulocytes.

Authors:  S Bréchard; C Melchior; S Plançon; V Schenten; E J Tschirhart
Journal:  Cell Calcium       Date:  2008-04-23       Impact factor: 6.817

7.  Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains.

Authors:  J L Gao; P M Murphy
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

8.  Counteracting effects of NADPH oxidase and the Na+/Ca2+ exchanger on membrane repolarisation and store-operated uptake of Ca2+ by chemoattractant-activated human neutrophils.

Authors:  Gregory R Tintinger; Ronald Anderson
Journal:  Biochem Pharmacol       Date:  2004-06-15       Impact factor: 5.858

9.  Inhibition of native TRPC6 channel activity by phosphatidylinositol 4,5-bisphosphate in mesenteric artery myocytes.

Authors:  Anthony P Albert; Sohag N Saleh; William A Large
Journal:  J Physiol       Date:  2008-05-08       Impact factor: 5.182

Review 10.  Regulation of superoxide production in neutrophils: role of calcium influx.

Authors:  Sabrina Bréchard; Eric J Tschirhart
Journal:  J Leukoc Biol       Date:  2008-06-10       Impact factor: 4.962

View more
  14 in total

Review 1.  What is the evidence for the role of TRP channels in inflammatory and immune cells?

Authors:  A Parenti; F De Logu; P Geppetti; S Benemei
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

2.  TRPing up reperfusion: neutrophil TRPM2 channels exacerbate necrosis and contractile dysfunction in post-ischaemic myocardium.

Authors:  Ronald J Korthuis; Theodore Kalogeris
Journal:  Cardiovasc Res       Date:  2012-12-11       Impact factor: 10.787

Review 3.  Detrimental or beneficial: the role of TRPM2 in ischemia/reperfusion injury.

Authors:  Kai-yu Zhan; Pei-lin Yu; Chun-hui Liu; Jian-hong Luo; Wei Yang
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 4.  Calcium signalling and related ion channels in neutrophil recruitment and function.

Authors:  Roland Immler; Scott I Simon; Markus Sperandio
Journal:  Eur J Clin Invest       Date:  2018-06-22       Impact factor: 4.686

5.  Colchicine modulates oxidative stress in serum and leucocytes from remission patients with Family Mediterranean Fever through regulation of Ca²+ release and the antioxidant system.

Authors:  Mehmet Sahin; A Cihangir Uğuz; Halil Demirkan; Mustafa Nazıroğlu
Journal:  J Membr Biol       Date:  2011-01-20       Impact factor: 1.843

6.  Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study.

Authors:  Micol Romano; Facundo Garcia-Bournissen; David Piskin; Ulkumen Rodoplu; Lizzy Piskin; Abdelbaset A Elzagallaai; Tunc Tuncer; Siren Sezer; Didar Ucuncuoglu; Tevfik Honca; Dimitri Poddighe; Izzet Yavuz; Peter Stenvinkel; Mahmut Ilker Yilmaz; Erkan Demirkaya
Journal:  Life (Basel)       Date:  2022-06-15

7.  Anti-tumor Necrosis Factor Alpha (Infliximab) Attenuates Apoptosis, Oxidative Stress, and Calcium Ion Entry Through Modulation of Cation Channels in Neutrophils of Patients with Ankylosing Spondylitis.

Authors:  Yunus Ugan; Mustafa Nazıroğlu; Mehmet Şahin; Mehmet Aykur
Journal:  J Membr Biol       Date:  2016-03-08       Impact factor: 1.843

8.  The ion channel transient receptor potential melastatin-2 does not play a role in inflammatory mouse models of chronic obstructive pulmonary diseases.

Authors:  Liz Hardaker; Parmjit Bahra; Benjamin Cochin de Billy; Mark Freeman; Natalia Kupfer; Daniel Wyss; Alexandre Trifilieff
Journal:  Respir Res       Date:  2012-04-04

9.  Reduced Necrosis and Content of Apoptotic M1 Macrophages in Advanced Atherosclerotic Plaques of Mice With Macrophage-Specific Loss of Trpc3.

Authors:  Sumeet Solanki; Prabhatchandra R Dube; Lutz Birnbaumer; Guillermo Vazquez
Journal:  Sci Rep       Date:  2017-02-10       Impact factor: 4.379

10.  Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists.

Authors:  Christelle Moreau; Tanja Kirchberger; Joanna M Swarbrick; Stephen J Bartlett; Ralf Fliegert; Timur Yorgan; Andreas Bauche; Angelika Harneit; Andreas H Guse; Barry V L Potter
Journal:  J Med Chem       Date:  2013-12-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.